| Issue |
J Oral Med Oral Surg
Volume 30, Number 2, 2024
|
|
|---|---|---|
| Article Number | 17 | |
| Number of page(s) | 3 | |
| DOI | https://doi.org/10.1051/mbcb/2024015 | |
| Published online | 02 September 2024 | |
Letter to the Editor
Consensus of AIMOM (Association Internationale de Médecine Orale et Maxillo-faciale) on the management of drug-related osteochemonecrosis of the jaws in 2024
1
CHU Lille, Service de Stomatologie, de chirurgie orale et maxillo-faciale, 59000, Lille, France
2
Département universitaire de Stomatologie, de Chirurgie orale et maxillo-faciale Université Université de Lille UFR3S, 59000, Lille, France
3
University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Department of Oral and Maxillofacial surgery, 63000, Clermont-Ferrand, France
4
CHU Lille, Inserm U1008 - Controlled Drug Delivery Systems and Biomaterials, 59000, Lille, France
5
UMR Inserm/UdA, U1107, Neuro-Dol, Trigeminal Pain and Migraine, Université d’Auvergne, 63003, Clermont-Ferrand, France
* Correspondence: ferri.joel@gmail.com
Received:
27
May
2024
Accepted:
31
May
2024
This article has no abstract.
© The authors, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
